Wednesday, 13 November 2013

Study shows decrease in sepsis mortality rates




A recent study from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis. The results suggest that substantial improvements in patient outcomes can be accomplished by improving processes of care and working with existing treatments in a novel way.


The study, which is published online in Critical Care Medicine, was led by senior author Allan J. Walkey, MD, MSc, assistant professor of medicine, BUSM, and attending physician, pulmonary, and allergy medicine, BMC.


Severe sepsis, which affects approximately one million Americans each year, occurs when a local infection causes other organs in the body to fail. For example, a patient with severe sepsis could have an infection that starts as pneumonia, but a counterproductive immune response results in damage to distant organs, such as new onset kidney failure, altered mental status and/or dangerously low blood pressure (shock). It can be imminently life threatening - approximately one out of three patients die from severe sepsis during their hospitalization.


Because prior studies suggesting a decrease in severe sepsis used only billing codes from administrative data, it was thought that billing code changes may be responsible for the mortality decline. To avoid administrative data issues and determine trends in patients prospectively identified as having severe sepsis, this study looked at data from patients with severe sepsis enrolled in 36 multicenter clinical trials from 1991-2009.


The results showed that despite no change over time in the severity of illness of the patients with severe sepsis enrolled in the , mortality rates declined significantly over 20 years, and the decline occurred without the development of new pharmacological therapies targeted to treat severe sepsis.


Previous studies have suggested that having more critical care physicians providing care, earlier initiation of antibiotics, more targeted delivery of intravenous fluids and more gentle mechanical ventilation may improve outcomes of patients with severe sepsis. However, whether findings from these past studies were implemented into routine practice and were associated with improved severe sepsis patient outcomes in the real world was previously unclear.


"Even without new drugs or technologies to treat severe sepsis, our study suggests that improving the ways in which we recognize and deliver care to patients with severe could decrease mortality rates by a magnitude similar to new effective drug," said Walkey.


Additional studies are needed to determine what specific changes in care have had the most impact on decreasing the mortality rates of with .



Medical Xpress on facebook

Related Stories


BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death


Nov 13, 2011



A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.



Nationwide trends for sepsis in the 21st century


Aug 18, 2011



Severe sepsis is common and often fatal, although evidence-based therapies have improved patient outcomes.



Rising rates of severe and fatal sepsis during labor and delivery


Sep 23, 2013



Rates of severe sepsis and deaths from sepsis among U.S. women hospitalized for delivery have risen sharply over the last decade, reports a study in the October issue of Anesthesia & Analgesia, official journal of the In ...



Lack of consensus among health care providers in identifying sepsis poses threat to treatment


Apr 16, 2013



Though the toll of sepsis is known to be enormous – it is estimated to cost the U.S. health care system $24.3 billion each year, and is the nation's third-leading killer, behind heart disease and cancer – the true magnitude ...



Drug does not significantly reduce risk of death among patients with severe sepsis


Mar 19, 2013



Administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect on reducing all-cause 28-day mortality or 1-year mortality, compared with placebo, according to ...



Recommended for you




Population aging crisis may have been overestimated


12 minutes ago



(HealthDay)—Use of an alternative measure for assessing the number of dependent older people suggests that the population aging crisis may have been overestimated, according to an analysis published online ...





Scientific issues relating to inorganic arsenic explored


32 minutes ago



(HealthDay)—The critical scientific issues in evaluating cancer and non-cancer effects of oral exposure to inorganic arsenic have been identified, according to a report published by the U.S. Environmental ...





Many would give private info to health insurers to save money


57 minutes ago



(HealthDay)—Many Americans say they'd submit to insurance company medical tests and lifestyle monitoring in exchange for lower-cost premiums, a new Harris Interactive/HealthDay poll finds.



CVI puts research into practice on firearms and domestic violence


1 hour ago



The Crime Victims' Institute (CVI) at Sam Houston State University initiated a new series of reports to help victim advocates translate the latest research in the field into practical services and resources for victims, beginning ...





Menstrual cycle influences concussion outcomes


2 hours ago



How well a woman recovers from a concussion may depend on that time of the month.



Schools help kids choose carrots over candy bars


2 hours ago



When schools adopt healthful nutrition policies and practices, kids' diets improve.



User comments








A recent study from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) shows a significant decrease in severe sepsis mortality rates over the past 20 years. Looking at data from patients with severe sepsis enrolled in clinical trials, researchers found that in-hospital mortality rates decreased from 47 percent between 1991 and 1995 to 29 percent between 2006 and 2009, a time period when no new pharmacological treatments were developed for severe sepsis. The results suggest that substantial improvements in patient outcomes can be accomplished by improving processes of care and working with existing treatments in a novel way.


The study, which is published online in Critical Care Medicine, was led by senior author Allan J. Walkey, MD, MSc, assistant professor of medicine, BUSM, and attending physician, pulmonary, and allergy medicine, BMC.


Severe sepsis, which affects approximately one million Americans each year, occurs when a local infection causes other organs in the body to fail. For example, a patient with severe sepsis could have an infection that starts as pneumonia, but a counterproductive immune response results in damage to distant organs, such as new onset kidney failure, altered mental status and/or dangerously low blood pressure (shock). It can be imminently life threatening - approximately one out of three patients die from severe sepsis during their hospitalization.


Because prior studies suggesting a decrease in severe sepsis used only billing codes from administrative data, it was thought that billing code changes may be responsible for the mortality decline. To avoid administrative data issues and determine trends in patients prospectively identified as having severe sepsis, this study looked at data from patients with severe sepsis enrolled in 36 multicenter clinical trials from 1991-2009.


The results showed that despite no change over time in the severity of illness of the patients with severe sepsis enrolled in the , mortality rates declined significantly over 20 years, and the decline occurred without the development of new pharmacological therapies targeted to treat severe sepsis.


Previous studies have suggested that having more critical care physicians providing care, earlier initiation of antibiotics, more targeted delivery of intravenous fluids and more gentle mechanical ventilation may improve outcomes of patients with severe sepsis. However, whether findings from these past studies were implemented into routine practice and were associated with improved severe sepsis patient outcomes in the real world was previously unclear.


"Even without new drugs or technologies to treat severe sepsis, our study suggests that improving the ways in which we recognize and deliver care to patients with severe could decrease mortality rates by a magnitude similar to new effective drug," said Walkey.


Additional studies are needed to determine what specific changes in care have had the most impact on decreasing the mortality rates of with .



Medical Xpress on facebook

Related Stories


BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death


Nov 13, 2011



A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.



Nationwide trends for sepsis in the 21st century


Aug 18, 2011



Severe sepsis is common and often fatal, although evidence-based therapies have improved patient outcomes.



Rising rates of severe and fatal sepsis during labor and delivery


Sep 23, 2013



Rates of severe sepsis and deaths from sepsis among U.S. women hospitalized for delivery have risen sharply over the last decade, reports a study in the October issue of Anesthesia & Analgesia, official journal of the In ...



Lack of consensus among health care providers in identifying sepsis poses threat to treatment


Apr 16, 2013



Though the toll of sepsis is known to be enormous – it is estimated to cost the U.S. health care system $24.3 billion each year, and is the nation's third-leading killer, behind heart disease and cancer – the true magnitude ...



Drug does not significantly reduce risk of death among patients with severe sepsis


Mar 19, 2013



Administration of the drug eritoran to patients with severe sepsis and septic shock failed to demonstrate a significant effect on reducing all-cause 28-day mortality or 1-year mortality, compared with placebo, according to ...



Recommended for you




Population aging crisis may have been overestimated


12 minutes ago



(HealthDay)—Use of an alternative measure for assessing the number of dependent older people suggests that the population aging crisis may have been overestimated, according to an analysis published online ...





Scientific issues relating to inorganic arsenic explored


32 minutes ago



(HealthDay)—The critical scientific issues in evaluating cancer and non-cancer effects of oral exposure to inorganic arsenic have been identified, according to a report published by the U.S. Environmental ...





Many would give private info to health insurers to save money


57 minutes ago



(HealthDay)—Many Americans say they'd submit to insurance company medical tests and lifestyle monitoring in exchange for lower-cost premiums, a new Harris Interactive/HealthDay poll finds.



CVI puts research into practice on firearms and domestic violence


1 hour ago



The Crime Victims' Institute (CVI) at Sam Houston State University initiated a new series of reports to help victim advocates translate the latest research in the field into practical services and resources for victims, beginning ...





Menstrual cycle influences concussion outcomes


2 hours ago



How well a woman recovers from a concussion may depend on that time of the month.



Schools help kids choose carrots over candy bars


2 hours ago



When schools adopt healthful nutrition policies and practices, kids' diets improve.



User comments








Categories:

0 comments:

Post a Comment